ulcerative colitis
Conditions
Interventions
The experimental group:Shenling Baizhu powder capsule combined with UC special prescription granules
The control group:Shenling Baizhu Powder placebo capsule combined with UC special prescription granules
Sponsors
Guangdong Provincial Hospital of Traditional Chinese Medicine
Eligibility
Sex/Gender
All
Age
18 Years to 75 Years
Inclusion criteria
Inclusion criteria: (1) 18-75 years old, male or female; (2) Meet the diagnostic criteria of ulcerative colitis; (3) Meet the criteria of mild and moderate active stage of ulcerative colitis; (4) Meet the criteria for waiting diagnosis of dampness obstruction syndrome of spleen deficiency; (5) The informed consent is signed.
Exclusion criteria
Exclusion criteria: (1) Chronic schistosomiasis, bacterial dysentery, intestinal tuberculosis and other infectious colitis, colonic Crohn's disease, radiation enteritis, ischemic enteritis; (2) Patients in lactation, pregnant women and intolerant to this drug; (3) patients with serious primary diseases such as heart, lung, liver, kidney and hematopoietic system, and mental illness; (4) Patients with serious complications such as local stenosis, toxic megacolon, intestinal obstruction, colon cancer, rectal cancer, intestinal perforation and anal diseases; (5) persons with disabilities defined by law (mute, deaf, blind, mental disorder, physical disability, intellectual disability). (6) Normal cognitive function, no dyslexia; Be able to actively cooperate and participate in investigation and research.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| UC Disease activity index; | — |
Secondary
| Measure | Time frame |
|---|---|
| Blood sedimentation and CRP;Ibd Quality of life Questionnaire;Intestinal mucosa endoscopic and pathological scores; | — |
Countries
China
Contacts
Public Contacthuangshaogang
Guangdong Provincial Hospital of Chinese Medicine
Outcome results
None listed